McCarthy Sean A. - Insider Non-Derivative Transactions at CytomX Therapeutics, Inc. (CTMX) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Aug 20, 2024, McCarthy Sean A.'s relationship to CytomX Therapeutics, Inc. (CTMX) is Director,Officer (CEO), and currently has 671,749 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other CTMX insiders.

Data Source: SEC.
McCarthy Sean A. - Insider Non-Derivative Transactions of CTMX Common Stock
McCarthy Sean A. - Insider Non-Derivative Transactions at CTMX
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Aug 21, 2024 Sell -- (Common Stock) 13898 1.23 657851
Aug 21, 2024 M -- (Common Stock) 37500 0 671749
Mar 27, 2024 M -- (Common Stock) 109768 1.57 634249
Mar 20, 2024 Sell -- (Common Stock) 20223 2.09 524481
Jan 19, 2024 Acquisition -- (Common Stock) 90000 0 544704
Dec 21, 2023 Sell -- (Common Stock) 13551 1.38 454704
Dec 18, 2023 M -- (Common Stock) 37500 0 468255
Sep 23, 2023 Sell -- (Common Stock) 14601 1.3 430755
Sep 21, 2023 Acquisition -- (Common Stock) 40000 0 445356
May 20, 2023 M -- (Common Stock) 16535 1.57 405356
Mar 17, 2023 Sell -- (Common Stock) 7121 1.88 388821
Feb 3, 2023 Acquisition -- (Common Stock) 105000 0 395942